Certain Biologics May Boost Infection Risk in Psoriasis Patients Certain Biologics May Boost Infection Risk in Psoriasis Patients
Psoriasis patients who are new users of infliximab and adalimumab appear to be at a greater risk of serious infection than those beginning therapy with etanercept, according to French researchers.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Dermatology News Source Type: news
More News: Dermatology | Enbrel | France Health | HIV AIDS | Humira | Infectious Diseases | Psoriasis | Remicade | Skin